Skip to main content
TipRanks
Go Ultimate75% OFF

Rahul D. Ballal Insider Profile

4 Followers

Rahul D. Ballal, Director at Agios Pharma, holds 15.23K shares in Agios Pharma (Ticker: AGIO), holds 22.34K shares in Enliven Therapeutics (Ticker: ELVN).

Rahul D. Ballal's Trading History

AGIO
Agios Pharma
Jun 23, 2026DirectorUninformative Buy96.19K$483.70K
ELVN
Enliven Therapeutics
Oct 10, 2024DirectorUninformative Buy146.92K$1.08M

You May Also Like

Rahul D. Ballal insider profile FAQ

What is the percentage of profitable transactions made by Rahul D. Ballal?
The percentage of profitable transactions made by Rahul D. Ballal is 100%.
What is the average return per transaction made by Rahul D. Ballal?
The average return per transaction made by Rahul D. Ballal is 18.20%.
What stocks does Rahul D. Ballal hold?
Rahul D. Ballal holds: AGIO, ELVN stocks.
What was Rahul D. Ballal’s latest transaction?
Rahul D. Ballal’s latest transaction was an Uninformative Buy of $96.19K.
What was Rahul D. Ballal's most profitable transaction?
Rahul D. Ballal’s most profitable transaction was an Informative Sell of ELVN stock on February 22, 2023. The return on the trade was 27.00%.
What is Rahul D. Ballal's role in Agios Pharma?
Rahul D. Ballal's role in Agios Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.